Sulagna Basu

3.0k total citations
60 papers, 1.3k citations indexed

About

Sulagna Basu is a scholar working on Molecular Medicine, Endocrinology and Pharmacology. According to data from OpenAlex, Sulagna Basu has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Medicine, 29 papers in Endocrinology and 17 papers in Pharmacology. Recurrent topics in Sulagna Basu's work include Antibiotic Resistance in Bacteria (41 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Vibrio bacteria research studies (14 papers). Sulagna Basu is often cited by papers focused on Antibiotic Resistance in Bacteria (41 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Vibrio bacteria research studies (14 papers). Sulagna Basu collaborates with scholars based in India, United Kingdom and United States. Sulagna Basu's co-authors include Subhasree Roy, Shanta Dutta, Rajlakshmi Viswanathan, Arun Singh, Somdatta Chatterjee, Saswati Datta, Suchandra Mukherjee, Ayan Mondal, Subhankar Mukherjee and Sharmi Naha and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Applied Microbiology and Biotechnology.

In The Last Decade

Sulagna Basu

53 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sulagna Basu India 24 798 412 347 318 278 60 1.3k
Yih‐Ru Shiau Taiwan 23 813 1.0× 371 0.9× 389 1.1× 146 0.5× 401 1.4× 32 1.5k
Joel T. Fishbain United States 15 750 0.9× 374 0.9× 241 0.7× 114 0.4× 344 1.2× 26 1.4k
Thomas Guillard France 24 946 1.2× 394 1.0× 308 0.9× 99 0.3× 313 1.1× 77 1.4k
Yunsop Chong South Korea 25 796 1.0× 609 1.5× 414 1.2× 144 0.5× 361 1.3× 86 1.6k
Marcelo Galas Argentina 21 667 0.8× 397 1.0× 243 0.7× 110 0.3× 214 0.8× 48 1.2k
Líbera Maria Dalla-Costa Brazil 22 669 0.8× 348 0.8× 394 1.1× 104 0.3× 293 1.1× 82 1.4k
A.T. Bernards Netherlands 22 699 0.9× 373 0.9× 328 0.9× 156 0.5× 236 0.8× 37 1.4k
Fernando Garcı́a-Garrote Spain 18 515 0.6× 413 1.0× 379 1.1× 207 0.7× 207 0.7× 42 1.2k
Jingyong Sun China 22 1.1k 1.3× 498 1.2× 268 0.8× 101 0.3× 450 1.6× 44 1.6k
María J. Pons Peru 21 627 0.8× 389 0.9× 209 0.6× 136 0.4× 209 0.8× 90 1.3k

Countries citing papers authored by Sulagna Basu

Since Specialization
Citations

This map shows the geographic impact of Sulagna Basu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sulagna Basu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sulagna Basu more than expected).

Fields of papers citing papers by Sulagna Basu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sulagna Basu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sulagna Basu. The network helps show where Sulagna Basu may publish in the future.

Co-authorship network of co-authors of Sulagna Basu

This figure shows the co-authorship network connecting the top 25 collaborators of Sulagna Basu. A scholar is included among the top collaborators of Sulagna Basu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sulagna Basu. Sulagna Basu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Roy, Partha, et al.. (2025). AHM-1: An Inclusion to the Arsenal of β-Lactam Resistance in Clostridioides difficile. ACS Infectious Diseases. 11(3). 653–664.
3.
Basu, Sulagna & Arun Kumar Singh. (2025). Mitigating antimicrobial resistance, a critical step towards saving newborns: still miles to go. The Lancet Global Health. 13(5). e783–e784.
5.
Mukherjee, Subhankar, et al.. (2021). Neonatal Sepsis: The Impact of Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae. Frontiers in Medicine. 8. 634349–634349. 48 indexed citations
7.
Roy, Subhasree, et al.. (2021). CRISPR-Cas system, antibiotic resistance and virulence in bacteria: Through a common lens. Progress in molecular biology and translational science. 178. 123–174. 8 indexed citations
8.
Mukherjee, Suchandra, et al.. (2019). Evaluation of co-transfer of plasmid-mediated fluoroquinolone resistance genes and blaNDM gene in Enterobacteriaceae causing neonatal septicaemia. Antimicrobial Resistance and Infection Control. 8(1). 46–46. 29 indexed citations
9.
Bose, Dipro, Moumita Mondal, Ayan Mondal, et al.. (2016). Role in proinflammatory response of YghJ, a secreted metalloprotease from neonatal septicemic Escherichia coli. International Journal of Medical Microbiology. 306(7). 554–565. 13 indexed citations
10.
Chatterjee, Somdatta, et al.. (2014). The high prevalence of serine protease autotransporters of Enterobacteriaceae (SPATEs) in Escherichia coli causing neonatal septicemia. European Journal of Clinical Microbiology & Infectious Diseases. 33(11). 2015–2024. 27 indexed citations
11.
Roy, Subhasree, Rajni Gaind, Harish Chellani, et al.. (2013). Neonatal septicaemia caused by diverse clones of Klebsiella pneumoniae & Escherichia coli harbouring blaCTX-M-15.. PubMed. 137(4). 791–9. 23 indexed citations
12.
Choudhury, Samrat Roy, et al.. (2013). Investigation of antimicrobial physiology of orthorhombic and monoclinic nanoallotropes of sulfur at the interface of transcriptome and metabolome. Applied Microbiology and Biotechnology. 97(13). 5965–5978. 25 indexed citations
13.
Choudhury, Samrat Roy, Subhasree Roy, Arunava Goswami, & Sulagna Basu. (2012). Polyethylene glycol-stabilized sulphur nanoparticles: an effective antimicrobial agent against multidrug-resistant bacteria. Journal of Antimicrobial Chemotherapy. 67(5). 1134–1137. 54 indexed citations
14.
Viswanathan, Rajlakshmi, et al.. (2011). Experience of Setting up a Microbiology Service for Rural Facility-Based Sick Newborn Care Unit. Journal of Tropical Pediatrics. 58(1). 80–81. 2 indexed citations
15.
Roy, Subhasree, Arun Singh, Rajlakshmi Viswanathan, Ranjan K. Nandy, & Sulagna Basu. (2011). Transmission of imipenem resistance determinants during the course of an outbreak of NDM-1 Escherichia coli in a sick newborn care unit. Journal of Antimicrobial Chemotherapy. 66(12). 2773–2780. 47 indexed citations
16.
Mukherjee, Suchandra, et al.. (2011). CTX-M-9 group extended-spectrum β-lactamases in neonatal stool isolates: Emergence in India. Indian Journal of Medical Microbiology. 29(3). 305–308. 4 indexed citations
17.
Viswanathan, Rajlakshmi, Sulagna Basu, Ashwin Dalal, et al.. (2011). Case reports. Indian Pediatrics. 48(5). 397–407. 17 indexed citations
18.
Viswanathan, Rajlakshmi, et al.. (2010). Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates. European Journal of Clinical Microbiology & Infectious Diseases. 29(12). 1495–1500. 26 indexed citations
19.
Viswanathan, Rajlakshmi, et al.. (2010). An outbreak of neonatal sepsis presenting with exanthematous rash caused by Klebsiella pneumoniae. Epidemiology and Infection. 139(2). 226–228. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026